Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)
|
3 Months Ended | 6 Months Ended | 7 Months Ended | 12 Months Ended | 115 Months Ended | 121 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 30, 2013
|
Nov. 30, 2012
|
Nov. 30, 2013
|
Nov. 30, 2012
|
May 31, 2004
|
May 31, 2013
|
May 31, 2012
|
May 31, 2011
|
May 31, 2010
|
May 31, 2009
|
May 31, 2008
|
May 31, 2007
|
May 31, 2006
|
May 31, 2005
|
May 31, 2013
|
Nov. 30, 2013
|
|
Class of Stock [Line Items] | ||||||||||||||||
Net loss | $ 3,587,593 | $ 1,908,486 | $ 6,161,144 | $ 4,723,652 | $ 345,914 | $ 9,568,301 | $ 7,474,224 | $ 3,719,688 | $ 3,359,865 | $ 1,306,004 | $ 1,193,684 | $ 2,610,070 | $ 2,053,944 | $ 777,083 | $ 32,400,907 | $ 38,562,054 |
Accumulated deficit | 40,163,966 | 40,163,966 | 34,002,819 | 34,002,819 | 40,163,966 | |||||||||||
Working capital deficit | 7,973,301 | 7,973,301 | 2,388,138 | 2,388,138 | 7,973,301 | |||||||||||
Estimated future unvested option forfeitures | 0.00% | 0.00% | ||||||||||||||
Preferred Stock Shares authorized to be issued | 5,000,000 | 5,000,000 | ||||||||||||||
Deferred offering costs | 96,929 | 96,929 | 96,930 | 677,327 | 96,930 | 96,929 | ||||||||||
Common stock options and warrants to purchase | 95,100 | 95,100 | 95,100 | 98,900 | 95,100 | 95,100 | ||||||||||
Common stock options and warrants to purchase | 34,366,833 | 17,968,340 | 18,146,938 | 10,327,664 | 18,146,938 | |||||||||||
Face amount of notes | 7,221,250 | 7,221,250 | 6,588,250 | 6,588,250 | 7,221,250 | |||||||||||
Additional common shares if convertible debt is converted to common stock | 6,182,179 | 8,106,282 | ||||||||||||||
Unrecognized benefits | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
Direct costs associated with the convertible notes | 120,000 | |||||||||||||||
Amortization of deferred offering costs | 96,668 | 116,668 | 116,668 | |||||||||||||
Deferred finance costs, current | 3,332 | 3,332 | 3,332 | |||||||||||||
Minimum
|
||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||
Fixed conversion prices range | $ 0.65 | $ 0.65 | ||||||||||||||
Maximum
|
||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||
Fixed conversion prices range | $ 0.75 | $ 0.75 | ||||||||||||||
Convertible Debt
|
||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||
Face amount of notes | 4,621,250 | 4,621,250 | 6,021,250 | 6,021,250 | 4,621,250 | |||||||||||
Equity Securities
|
||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||
Deferred offering costs | 2,084,000 | 2,084,000 | 2,084,000 | |||||||||||||
Stock Rescission Liability
|
||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||
Deferred offering costs | $ 97,000 | $ 97,000 | $ 97,000 | $ 97,000 | $ 97,000 | |||||||||||
Series B convertible preferred stock
|
||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||
Common stock options and warrants to purchase | 95,100 | 95,100 | 95,100 | 95,100 | 95,100 | |||||||||||
Common shares issued upon conversion of preferred stock | 951,000 | 951,000 | ||||||||||||||
Series B Convertible Preferred Stock
|
||||||||||||||||
Class of Stock [Line Items] | ||||||||||||||||
Preferred Stock Shares authorized to be issued | 400,000 | 400,000 | 400,000 | 400,000 | 400,000 | 400,000 |